These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6374799)

  • 1. New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan.
    Bonadonna G; Bignami P; Buzzoni R; Moliterni A; Valagussa P; Veronesi U
    Recent Results Cancer Res; 1984; 91():210-3. PubMed ID: 6374799
    [No Abstract]   [Full Text] [Related]  

  • 2. Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results.
    Bonadonna G; Zambetti M; Valagussa P
    JAMA; 1995 Feb; 273(7):542-7. PubMed ID: 7837388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancer.
    Silvestrini R; Luisi A; Zambetti M; Cipriani S; Valagussa P; Bonadonna G; Daidone MG
    Int J Cancer; 2000 Aug; 87(3):405-11. PubMed ID: 10897047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy for node-negative breast cancer patients.
    Bonadonna G; Zambetti M; Valagussa P
    Recent Results Cancer Res; 1989; 115():175-9. PubMed ID: 2516350
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant combination chemotherapy for operable breast cancer. Trials in progress at the Istituto Nazionale Tumori of Milan.
    Bonadonna G; Rossi A; Tancini G; Bajetta E; Marchini S; Brambilla C; Tesoro Tess JD; Valagussa P; Banfi A; Veronesi U
    Cancer Treat Rep; 1981; 65 Suppl 1():61-5. PubMed ID: 7034930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy for lymph node-negative, estrogen receptor-negative breast cancer: a tale of three trials.
    Albain KS
    J Natl Cancer Inst; 2004 Dec; 96(24):1801-4. PubMed ID: 15601631
    [No Abstract]   [Full Text] [Related]  

  • 7. Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
    Gelber RD
    Recent Results Cancer Res; 1984; 96():102-9. PubMed ID: 6396763
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes.
    Buzzoni R; Bonadonna G; Valagussa P; Zambetti M
    J Clin Oncol; 1991 Dec; 9(12):2134-40. PubMed ID: 1960555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near-final word on adjuvant chemotherapy for breast cancer is good news.
    Vastag B
    J Natl Cancer Inst; 2005 Aug; 97(16):1178-9. PubMed ID: 16106020
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant programs for postmenopausal women with node-positive breast cancer: preliminary analysis of 5-year results.
    Rossi A; Brambilla C; Valagussa P; Bonadonna G
    Recent Results Cancer Res; 1984; 96():178-83. PubMed ID: 6396772
    [No Abstract]   [Full Text] [Related]  

  • 11. Review: experience of randomized trials without surgical controls.
    Tormey DC
    Recent Results Cancer Res; 1984; 96():184-7. PubMed ID: 6396773
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.
    Francis P; Crown J; Di Leo A; Buyse M; Balil A; Andersson M; Nordenskjöld B; Lang I; Jakesz R; Vorobiof D; Gutiérrez J; van Hazel G; Dolci S; Jamin S; Bendahmane B; Gelber RD; Goldhirsch A; Castiglione-Gertsch M; Piccart-Gebhart M;
    J Natl Cancer Inst; 2008 Jan; 100(2):121-33. PubMed ID: 18182617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy: Adjuvant chemotherapy in older patients with breast cancer.
    Jager A; Verweij J; Sleijfer S
    Nat Rev Clin Oncol; 2009 Oct; 6(10):563-5. PubMed ID: 19786999
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary chemotherapy for resectable breast cancer.
    Bonadonna G; Veronesi U; Brambilla C; Ferrari L; Passoni P; Coopmans de Yoldi GF; Luini A; Greco M; Valagussa P
    Recent Results Cancer Res; 1993; 127():113-7. PubMed ID: 8502807
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant therapy in primary breast cancer.
    Wolmark N; Fisher B
    Surg Clin North Am; 1985 Feb; 65(1):161-80. PubMed ID: 3887616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide, methotrexate, and fluorouracil with and without doxorubicin in the adjuvant treatment of resectable breast cancer with one to three positive axillary nodes.
    Moliterni A; Bonadonna G; Valagussa P; Ferrari L; Zambetti M
    J Clin Oncol; 1991 Jul; 9(7):1124-30. PubMed ID: 2045854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen and combination chemotherapy as adjuvant treatment in postmenopausal women with breast cancer.
    Wallgren A; Baral E; Beling U; Carstensen J; Friberg S; Glas U; Kaigas M; Skoog L
    Recent Results Cancer Res; 1984; 96():197-203. PubMed ID: 6396775
    [No Abstract]   [Full Text] [Related]  

  • 18. Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal results.
    Mathé G; Misset JL; Plagne R; Reizenstein P; Belpomme D; Le Mevel B; Guerrin J; Fumoleau P; Metz R; Delgado M
    Drugs Exp Clin Res; 1986; 12(1-3):143-5. PubMed ID: 3525068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant systemic therapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group's trials of cyclophosphamide or CMF in premenopausal and tamoxifen in postmenopausal patients.
    Mouridsen HT; Rose C; Brincker H; Thorpe SM; Rank F; Fischerman K; Andersen KW
    Recent Results Cancer Res; 1984; 96():117-28. PubMed ID: 6396765
    [No Abstract]   [Full Text] [Related]  

  • 20. Preoperative (neoadjuvant) chemotherapy for breast cancer: outline of the British Columbia Trial.
    Ragaz J
    Recent Results Cancer Res; 1986; 103():85-94. PubMed ID: 3526477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.